BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 22186068)

  • 1. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
    Zhang J; Huang Z; Sun R; Tian Z; Wei H
    J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
    Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
    Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
    Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O
    J Autoimmun; 1996 Oct; 9(5):645-51. PubMed ID: 8933280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
    Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
    J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
    Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
    Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
    J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ; Zhou ZG; Su H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
    Rothe H; O'Hara RM; Martin S; Kolb H
    Diabetologia; 1997 Jun; 40(6):641-6. PubMed ID: 9222642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.
    Rothe H; Jenkins NA; Copeland NG; Kolb H
    J Clin Invest; 1997 Feb; 99(3):469-74. PubMed ID: 9022080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
    Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
    Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines.
    Vultaggio A; Nencini F; Pratesi S; Maggi L; Guarna A; Annunziato F; Romagnani S; Parronchi P; Maggi E
    J Immunol; 2011 Apr; 186(8):4707-15. PubMed ID: 21389257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
    Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effects of andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance.
    Zhang C; Gui L; Xu Y; Wu T; Liu D
    Int Immunopharmacol; 2013 Aug; 16(4):451-6. PubMed ID: 23707775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.